[NBY] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[NBY] NovaBay Pharmaceuticals, Inc.
Announcement Date
26-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- -60.23%
Quarter Report
NBY's Result
NBY's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 14,404 8,421 9,934 6,599 12,508 18,230 11,897 3.23%
PBT -10,608 -5,824 -11,034 -9,652 -6,541 -7,400 -13,149 -3.51%
Tax -3,809 -4,615 5 6 4 3 2 -
NP -16,265 -6,559 -11,039 -10,487 -6,545 -7,403 -13,151 3.60%
Tax Rate - - - - - - - -
Total Cost 30,669 14,980 20,973 17,086 19,053 25,633 25,048 3.43%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -112.92 -77.89 -111.12 -158.92 -52.33 -40.61 -110.54 0.35%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -353.59 -184.09 -385.53 -593.63 -473.83 -591.81 0.00 -
EPS Diluted -353.59 -184.09 -385.53 -593.63 -564.17 -591.81 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.